Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo R Rueda

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|February 13, 2014
Adrenomedullin is a therapeutic target in colorectal cancerLiangjing Wang, Manish Gala, Masayoshi Yamamoto, et al.
Aging Cell|September 18, 2012
Prolonging the female reproductive lifespan and improving egg quality with dietary omega-3 fatty acidsDeepika Nehra, Hau D Le, Erica M Fallon, et al.
Cell Reports|March 7, 2019
A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical CarcinogenesisChunbo He, Xiangmin Lv, Cong Huang, et al.
Stem Cells (Dayton, Ohio)|October 10, 2009
CD133 expression defines a tumor initiating cell population in primary human ovarian cancerMichael D Curley, Vanessa A Therrien, Christine L Cummings, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 15, 2019
Timely expression and activation of YAP1 in granulosa cells is essential for ovarian follicle developmentXiangmin Lv, Chunbo He, Cong Huang, et al.
British Journal of Cancer|October 5, 2024
Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancerYao Sun, Zhenzhen Yin, Shuang Li, et al.
Nature Medicine|August 30, 2005
Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cellsYusuke Mizukami, Won-Seok Jo, Eva-Maria Duerr, et al.
Oncotarget|May 26, 2018
Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveauKristen Starbuck, Linah Al-Alem, David A Eavarone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2012
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinomaJean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Dual HER2 targeting impedes growth of HER2 gene-amplified uterine serous carcinoma xenograftsJolijn W Groeneweg, Silvia F Hernandez, Virginia F Byron, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|February 13, 2014
Adrenomedullin is a therapeutic target in colorectal cancerLiangjing Wang, Manish Gala, Masayoshi Yamamoto, et al.
Aging Cell|September 18, 2012
Prolonging the female reproductive lifespan and improving egg quality with dietary omega-3 fatty acidsDeepika Nehra, Hau D Le, Erica M Fallon, et al.
Cell Reports|March 7, 2019
A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical CarcinogenesisChunbo He, Xiangmin Lv, Cong Huang, et al.
Stem Cells (Dayton, Ohio)|October 10, 2009
CD133 expression defines a tumor initiating cell population in primary human ovarian cancerMichael D Curley, Vanessa A Therrien, Christine L Cummings, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 15, 2019
Timely expression and activation of YAP1 in granulosa cells is essential for ovarian follicle developmentXiangmin Lv, Chunbo He, Cong Huang, et al.
British Journal of Cancer|October 5, 2024
Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancerYao Sun, Zhenzhen Yin, Shuang Li, et al.
Nature Medicine|August 30, 2005
Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cellsYusuke Mizukami, Won-Seok Jo, Eva-Maria Duerr, et al.
Oncotarget|May 26, 2018
Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveauKristen Starbuck, Linah Al-Alem, David A Eavarone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2012
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinomaJean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Dual HER2 targeting impedes growth of HER2 gene-amplified uterine serous carcinoma xenograftsJolijn W Groeneweg, Silvia F Hernandez, Virginia F Byron, et al.
Pageof 13